Tag: Risk Information

CHC_DTCadvertisement2

01/17/2022

OPDP, Lilly Come to Terms Over TV Ads for Migraine Drug

CHC_general1

02/23/2021

OPDP Focuses on Misleading Opioid Claims Amid National Crisis

12/14/2020

Azurity Email Garners OPDP Enforcement Letter for False/Misleading Claims

CHC_FDA-Regulatory Images1

06/19/2019

OPDP Untitled Letter Cites False, Misleading Claims about Efficacy, Risk Presentation for Obesity Drug

CHC_DTCadvertisement1

10/19/2018

OPDP Guidance on Presenting Risk, Efficacy Info in DTC Ads Calls for Consumer-friendly Approaches

CHC_FDA-Regulatory Images1

11/17/2017

DTC Docket Draws Health Professional, Consumer Comments

CHC_DTCadvertisement1

10/16/2017

FDA Regulations on DTC Risk Information Could Be Backfiring

CHC_DTCadvertisement2

08/11/2017

Limiting Risk Disclosures in DTC Ads Improves Recall of Risk, FDA Study Shows

CHC_DTCadvertisement2

06/20/2017

OPDP to Conduct DTC Survey about Internet Access, Opening Risk Statements